Literature DB >> 10935412

[A case of G-CSF-producing large cell carcinoma of the lung with gastric metastasis].

T Fukata1, S Fukino, E Hayashi, K Okada, N Tamai, H Nakashima.   

Abstract

We report a rare surgically-treated case of G-CSF-producing large cell carcinoma of the lung with gastric metastasis. A 65-year-old male was admitted to our hospital because of fever, anemia and epigastralgia. Chest X-ray examination and CT scanning revealed a round mass shadow (8 cm) in contact with the chest wall in the right upper lung field and metastasis to the mediastinal lymph nodes. Laboratory examination showed a WBC of 16,800/mm3, CRP of 11.6 mg/dl, and a serum G-CSF of 90 pg/ml. Upper gastrointestinal series and gastroscopy showed an ulcerating submucosal tumorous lesion in the pyloric antrum. The lung carcinoma was treated by right upper lobectomy with chest wall resection. After 1 month, gastrectomy was performed. After the operation, the WBC normalized, and the CRP and serum G-CSF levels decreased. Histopathological examination demonstrated a poorly differentiated large cell carcinoma in the lung and a metastatic lesion in the stomach. Immunohistochemical staining with anti-G-CSF mono-clonal antibody showed negative results in the lung but positive results in the stomach. He was discharged 3 weeks after gastrectomy but died of aggravation of the general condition associated with local recurrence in the chest wall 2 months after discharge.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10935412

Source DB:  PubMed          Journal:  Kyobu Geka        ISSN: 0021-5252


  2 in total

1.  Granulocyte-colony-stimulating factor-producing gastric metastasis from large cell type lung cancer.

Authors:  Yasuo Yoshinaga; Hirokazu Kiyozaki; Shinichiro Okada; Fumio Konishi; Shigeki Yamada
Journal:  Clin J Gastroenterol       Date:  2010-12-15

2.  Gastrointestinal metastasis of primary lung cancer: An analysis of 366 cases.

Authors:  Yue Hu; Noah Feit; Yanqin Huang; Wenhong Xu; Shu Zheng; Xiuzhen Li
Journal:  Oncol Lett       Date:  2018-04-25       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.